3 Einträge gefunden

1. Factors affecting the unexpected failure of DCE-MRI to determine the optimal biological dose of the vascular targeting agent NGR-hTNF in solid cancer patients.

   1. Desar, [Unbekannt]
   2. Ingrid, M E
   3. Herpen, van
   4. Carla, M L
   5. Asten, van
   6. Jack, J A
   7. Fiedler, Walter

   2011 - Forschungsinformationssystem des UKE
2. A phase I study of recombinant human interleukin-21 (rIL-21) in combination with sunitinib in patients with metastatic renal cell carcinoma (RCC).

   1. Grünwald, Viktor
   2. Desar, Ingrid M E
   3. Haanen, John
   4. Fiedler, Walter
   5. Mouritzen, Ulrik
   6. Olsen, M W Brændholt
   7. Herpen, van

   2011 - Forschungsinformationssystem des UKE
3. Effective strategies for management of hypertension after vascular endothelial growth factor signaling inhibition therapy: results from a phase II randomized, factorial, double-blind study of Cediranib in patients with advanced solid tumors.

   1. Langenberg, Marlies H G
   2. Herpen, van
   3. Carla, M L
   4. Johann, De Bono
   5. Schellens, Jan H M
   6. Unger, Clemens
   7. Hoekman, Klaas

   2009 - Forschungsinformationssystem des UKE